Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity

Overview of attention for article published in Frontiers in oncology, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 792 followers.

Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, ... https://t.co/TSgUC9WtgH

04 Jul 2021

Reply Repost Favourite

Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity https://t.co/TSgUC9WtgH

25 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.